drugset / Trial / NCT07257627
Comparative PK/PD of Single-Dose THDB0206 at Different Injection Sites
RandomizedCrossoverOpen-labelTreatment
Summary
This open-label, randomized, three-period crossover, 8-hour hyperinsulinemic-euglycemic clamp study will compare the pharmacokinetic and pharmacodynamic profiles of THDB0206 after single subcutaneous administration at different injection sites in healthy Chinese adults.
Timeline
- Start
- 2024-04-17
- Primary completion
- 2024-12-02
- Completion
- 2024-12-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | THDB0206 | Unknown | 0.2 iu/kg | Subcutaneous |
Indications
No indication recorded.